| CA-19-9, Gastric & Pancreatic Cancer, ELISA Kit
| CA-19-9, Gastric & Pancreatic Cancer, ELISA Kit
| |
| CA-19-9 Gastrointestinal Tumor Assoc Marker 19-9, Sialyl Lacto-N-fucopentose, Lewis A, Cl: B46,Mab anti-Hu,frozen/paraffin
| CA-19-9 Gastrointestinal Tumor Assoc Marker 19-9, Sialyl Lacto-N-fucopentose, Lewis A, Cl: B46,Mab anti-Hu,frozen/paraffin
| |
| CA242 (GASTROINTESTINAL CANCER) | CA242 (GASTROINTESTINAL CANCER) | |
| CagA(Standard Range: 0-240 RU/ml //sensit. vs Western Blot: 93.7 )
| CagA(Standard Range: 0-240 RU/ml //sensit. vs Western Blot: 93.7 %)
| |
| CAGCCATGGCTG, 5'-NON-PHOSPHORYLATED | CAGCCATGGCTG, 5'-NON-PHOSPHORYLATED | |
| CAGCCATGGCTG, 5'-PHOSPHORYLATED | CAGCCATGGCTG, 5'-PHOSPHORYLATED | |
| CAEVM protocol | CAEVM protocol | |
| CAFLVKEVTKLIDNNKTEKEIL | CAFLVKEVTKLIDNNKTEKEIL | |
| C3a [Fmoc-Glu70, Ala71,72, Lys74] (70-77) [Fmoc-Glu-Ala-Ala-Leu-Lys-Leu-Ala-Arg]
| C3a [Fmoc-Glu70, Ala71,72, Lys74] (70-77) [Fmoc-Glu-Ala-Ala-Leu-Lys-Leu-Ala-Arg]
| |
| CAf1M protein | CAf1M protein | 141911-75-3 |
| CAGED CA2+ CHANNEL ANTAGONIST | CAGED CA2+ CHANNEL ANTAGONIST | 154026-67-2 |
| caged FEDA-ATP | caged FEDA-ATP | |
| caged sphingosine 1-phosphate | caged sphingosine 1-phosphate | |
| caged isocitrate | caged isocitrate | |
| 'CAGED GTP | 'CAGED GTP | 125455-57-4 |
| CAGED GLUTAMIC ACID | CAGED GLUTAMIC ACID | |
| CAGED GABA | CAGED GABA | |
| CAGED ASPARTIC ACID, SODIUM SALT | CAGED ASPARTIC ACID, SODIUM SALT | |
| CAGED CGMP | CAGED CGMP | |
| Caged Glutamic Acid, Sodium Salt | Caged Glutamic Acid, Sodium Salt | |
| Caged GTP, Dimethoxy-, Trisodium Salt | Caged GTP, Dimethoxy-, Trisodium Salt | |
| Caged GABA, Sodium Salt | Caged GABA, Sodium Salt | |
| Caged Ins(1,4,5)P3, L pack
| Caged Ins(1,4,5)P3, L pack
| |
| Caged Ins(1,4,5)P3, S pack
| Caged Ins(1,4,5)P3, S pack
| |
| CAGED FLUORESCEIN
| CAGED FLUORESCEIN
| |
| CAGED FLUORESCEIN SULFO-OSU
| CAGED FLUORESCEIN SULFO-OSU
| |
| CAGED INS(1,4,5)P3, TRISODIUM SALT | CAGED INS(1,4,5)P3, TRISODIUM SALT | |
| CAGED ATP, DISODIUM SALT | CAGED ATP, DISODIUM SALT | 171800-68-3 |
| CAGED D-ERYTHRO-SPHINGOSINE-1-PHOSPHATE | CAGED D-ERYTHRO-SPHINGOSINE-1-PHOSPHATE | 207516-11-8 |
| CAGED FLUORESCEIN MALEIMIDE | CAGED FLUORESCEIN MALEIMIDE | |
| CA(FOD)2 | CA(FOD)2 | 36885-29-7 |
| CAGED FLUORESCEIN MALEIMIDE* | CAGED FLUORESCEIN MALEIMIDE* | 167776-24-1 |
| caged AIP | caged AIP | |
| CAGEDFULLERENEDERIVATIVE | CAGEDFULLERENEDERIVATIVE | |
| caged cyclic ADP-ribose | caged cyclic ADP-ribose | |
| caged nuclear localization signal | caged nuclear localization signal | |
| CA150, exon 1 (Transcription Factor CA150, TCERG1, Transcription Elongation Regulator 1, TAF2S, TATA Box-Binding Protein-Associated Factor 2S)
| CA150, exon 1 (Transcription Factor CA150, TCERG1, Transcription Elongation Regulator 1, TAF2S, TATA Box-Binding Protein-Associated Factor 2S)
| |
| CAGDOWN PRIMER | CAGDOWN PRIMER | |
| Cage for Fused Silica Column | Cage for Fused Silica Column | |
| CAGDRLTGIPSHILNSSPSD | CAGDRLTGIPSHILNSSPSD | |
| cager-2 protein | cager-2 protein | |
| CAF-PH protocol | CAF-PH protocol | |
| cager-1 protein | cager-1 protein | |
| 5' CAG GAA ACA GCT ATG ACC 3' | 5' CAG GAA ACA GCT ATG ACC 3' | |
| CAGGCGCCTG, 5'-NON-PHOSPHORYLATED | CAGGCGCCTG, 5'-NON-PHOSPHORYLATED | |
| CAGGCGCCTG, 5'-PHOSPHORYLATED | CAGGCGCCTG, 5'-PHOSPHORYLATED | |
| CAF-1 protein, Drosophila | CAF-1 protein, Drosophila | |
| caf1 protein, Yersinia pestis | caf1 protein, Yersinia pestis | |
| CAF protocol 2 | CAF protocol 2 | |
| CAF protocol | CAF protocol | |
| CA 19-9 (GI Cancer Marker Test)
| CA 19-9 (GI Cancer Marker Test)
| |
| CAFRQVCHTTVPWPNASLTP | CAFRQVCHTTVPWPNASLTP | |
| CAFTARIC ACID | CAFTARIC ACID | 67879-58-7 |
| CAFTARIC ACID(AHP) | CAFTARIC ACID(AHP) | |
| Caftaric acid o-quinone | Caftaric acid o-quinone | |
| CAFVP protocol | CAFVP protocol | |
| CA549 glycoprotein | CA549 glycoprotein | |
| 7C-aglycone | 7C-aglycone | 51732-61-7 |
| 5C-aglycone | 5C-aglycone | 34927-45-2 |
| CA GLYCEROPHOSPHATE | CA GLYCEROPHOSPHATE | |
| cagocel-1 | cagocel-1 | 115774-57-7 |
| CAG1 protein | CAG1 protein | 147387-25-5 |
| CAG protocol | CAG protocol | |
| CAG7 protein | CAG7 protein | |
| CAG Repeat Length Mutation in Huntington's Disease | CAG Repeat Length Mutation in Huntington's Disease | |
| CB-52 | CB-52 | 869376-90-9 |
| CB-86 | CB-86 | 1150586-64-3 |
| CB 80 | CB 80 | 1391054-76-4 |
| CB 300919 | CB 300919 | 289715-28-2 |
| CB 184 | CB 184 | 165307-47-1 |
| CB 30865 | CB 30865 | 206275-15-2 |
| CB 34 | CB 34 | |
| CB | CB | |
| 10CB | 4'-Decyl[1,1'-biphenyl]-4-carbonitril | 59454-35-2 |
| CB101 | CB101 | |
| CB28 | CB28 | |
| CB 54 | CB 54 | |
| CB 966 | CB 966 | 128312-71-0 |
| CB 182 | CB 182 | |
| CB 848 | CB 848 | 32808-58-5 |
| CB 844 | CB 844 | 32780-41-9 |
| CB105 | CB105 | |
| CB 34 | CB 34 | 193979-75-8 |
| CB-25 | CB-25 | 869376-63-6 |
| CB 13 | CB 13 | 432047-72-8 |
| CAGR1 protein | CAGR1 protein | |
| CaiA protein | CaiA protein | |
| CAGUP PRIMER | CAGUP PRIMER | |
| C(14a)-Homo-27-nor-14beta-gammaceran-3alpha-ol | C(14a)-Homo-27-nor-14beta-gammaceran-3alpha-ol | 24739-08-0 |
| C(14A)-HOMO-27-NORGCERA-13,15,17-TRIENE-3B,15,21A-TRIOL3,21-DIACETATE | C(14A)-HOMO-27-NORGCERA-13,15,17-TRIENE-3B,15,21A-TRIOL3,21-DIACETATE | |
| C(14A)-HOMO-27-NORGCER-14-ENE-3B,21A-DIOL21-ACETATE3-(3-(3,4-DIACETOXYPHENYL)PROPIONATE) | C(14A)-HOMO-27-NORGCER-14-ENE-3B,21A-DIOL21-ACETATE3-(3-(3,4-DIACETOXYPHENYL)PROPIONATE) | |
| C(14A)-HOMO-27-NOR-3B,14B,21A-GCERANETRIOL3,21-DIACETATE | C(14A)-HOMO-27-NOR-3B,14B,21A-GCERANETRIOL3,21-DIACETATE | |
| C(14A)-HOMO-27-NORGCER-14-ENE-3B,21A-DIOL21-ACETATE3-(3-(3,4-DIMETHOXYPHENYL)PROPIONATE) | C(14A)-HOMO-27-NORGCER-14-ENE-3B,21A-DIOL21-ACETATE3-(3-(3,4-DIMETHOXYPHENYL)PROPIONATE) | |
| C(14a)-Homo-27-nor-5α-gammacer-13-ene | C(14a)-Homo-27-nor-5α-gammacer-13-ene | 18070-14-9 |
| C(14a)-Homo-27-norgammacerane-3β,21α-diol | C(14a)-Homo-27-norgammacerane-3β,21α-diol | 18188-24-4 |
| (14β)-C(14a)-Homo-27-norgammacerane-3,21-dione | (14β)-C(14a)-Homo-27-norgammacerane-3,21-dione | 25329-73-1 |
| C(14a)-Homo-27-norgammacerane-3β,14β,21α-triol | C(14a)-Homo-27-norgammacerane-3β,14β,21α-triol | 28618-19-1 |
| C(14a)-Homo-27-norgammacera-14-ene-3,21-dione | C(14a)-Homo-27-norgammacera-14-ene-3,21-dione | 1449-07-6 |
| C(14a)-Homo-27-norgammacer-14-ene | C(14a)-Homo-27-norgammacer-14-ene | 18046-86-1 |
| C(14a)-Homo-27-norgammacer-14-ene-3β,20β,21β,24-tetrol | C(14a)-Homo-27-norgammacer-14-ene-3β,20β,21β,24-tetrol | 77311-65-0 |